Moneycontrol PRO
HomeNewscoronavirusCalculation of India’s Covid deaths complex, modelling changes can affect numbers: Ex-ICMR Scientist

Calculation of India’s Covid deaths complex, modelling changes can affect numbers: Ex-ICMR Scientist

Gangakhedkar, who was involved in the prevention and control strategies against the HIV epidemic in India, said such random modelling exercises threw surprising results while estimating HIV prevalence

May 07, 2022 / 11:51 IST
Representative image (Source: Reuters)

The calculation of deaths due to Covid-19 in India is “quite complex” and there are “no definite answers”, former Indian Council of Medical Research (ICMR) scientist Dr Raman Gangakhedkar told News18.com, responding to the latest data released by the World Health Organization (WHO), which claims that Covid could have killed as many as 47.4 lakh people in India in 2020-21.

The figure, disputed by the Indian government, is nearly 10 times the country’s official Covid death toll of 4.81 lakh at the end of 2021.

The epidemiologist, who was the face of the country’s apex medical research agency during government briefings on Covid-19 last year, said when a modelling exercise is done, certain assumptions have to be used when data is not available.

“India is a large country with a population over 134 crore. Here, health infrastructure, quality and timelines of data reporting vary between states. Use of one assumption for all states may not be appropriate,” he said.

Gangakhedkar, who was involved in the prevention and control strategies against the Human Immunodeficiency Virus (HIV) epidemic in India, said such random modelling exercises threw surprising results while estimating the prevalence of HIV in India.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“For instance, while estimating the number of HIV infections in India, in 2005-06, we tied up with the National Family Health Survey (NFHS). The sample size of the survey is large and representative to depend upon.” The estimated number for HIV-infected individuals for 2005 was 52.6 lakh.

“When the assumption was replaced with actual data from NFHS, the HIV estimate dropped to 25.4 lakh in 2006. Thus, using actual data from the NFHS, the disease burden dropped by half,” he said, while adding, “It wasn’t true, but this is how changing assumptions impacts modelling exercise.

They tend to inflate or deflate the original number. Otherwise, how was it possible that the prevalence of HIV got reduced by 50% within a year?”

Key Factors

Some key factors which play a crucial role in estimating disease-specific deaths are attribution, quality of registries and segregation of deaths due to other factors, he said.

Attribution is one of the most challenging parts. “Covid hits people with co-morbid conditions the most. It is difficult to attribute if the death was due to Covid or the co-morbid condition.”

Also, the quality registry system of births and deaths is not uniform in every state, especially remote districts of India. “It can be one of the very big reasons that the actual figures remain unavailable.”

Also, during the period of lockdown, people were not moving out of the house because of the fear of infection.

“Meanwhile, people who had developed or were already fighting deadly diseases such as tuberculosis and their diagnosis of treatment got delayed as they did not want to move out due to the fear of infection. A section of the population witnessed such deaths as well.”

Himani Chandna
Himani Chandna writes on healthcare and pharmaceuticals, policy, R&D and corporate updates, and has a ringside view of India’s battle against the Covid-19 outbreak. She has previously worked with ThePrint, Hindustan Times and The Indian Express in her decade-long career. She is a graduate in Economics, has done post-graduation from the IIMC, Delhi. A tea connoisseur who is fond of long drives to mountains and writing poetry.
first published: May 7, 2022 11:51 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347